Research  

 

Phenicell Research Institute is continuously researching stem cells to discover new therapies to help our patients with a variety of conditions. Ongoing stem cell research studies include the following:


Research

Study #1: SPINAL CORD INJURY STUDY with BONE MARROW and PRP

Background: This study is somewhat similar to the study by Jarocha's group in Poland published in Cell Transplant, March 2015. The results of the Polish group's research suggested that repeated intrathecal infusions of Mesenchymal Stem Cells (MSCs) might have the potential to produce clinically meaningful improvements for Phenicell Regenerative Institute patients.

ResearchOur Study: The purpose of our study was to evaluate the safety and efficacy of bone marrow aspirate concentration (BMAC) and Platelet-Rich Plasma (PRP) transplantations for a spinal cord injury (SCI). We harvested Autologous BMAC from the iliac crest and simultaneously injected it intravenously and intrathecally every 3 months. At the same time, we added PRP to the intrathecal BMAC.

We tested both the American Spinal Injury Association (ASIA) scores and the Oswestry Disability index (ODI) scores before and after injections. Our research paper entitled, Combination administration of Platelet rich plasma and autologous bone marrow aspirate concentrate for spinal cord injury: a descriptive case series was accepted for publication in 2020.

Research Article

In 2017, Dr. Shehadi published a research article titled: "Review of commercially available demineralized bone matrix products for spinal fusions: A selection paradigm”

The authors are Joseph A. Shehadi and Steven M. Elzein

Research


Ask the doctor